APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes

Yulan Jin, Xueqin Chen, Robert Podolsky, Diane Hopkins, Levi H Makala, Andy Muir, Jin-Xiong She

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

It is widely believed that CD4+CD25+ regulatory T cells (Treg) are defective in type 1 diabetes (T1D) and other autoimmune diseases. However, this conclusion is based on the suboptimal in vitro suppression results from very small numbers of subjects. Furthermore, the cells responsible for the suboptimal suppression have not been defined. Therefore, we carried out extensive in vitro suppression assays using both autologous and heterologous donors of Tregs, effector T cells and antigen-presenting cells (APC) from both T1D patients and normal controls. Our in vitro suppression data indicated that a significantly higher proportion (40.0%) of T1D patients have "very low suppression" activity (defined as < 25%) by autologous Treg compared to controls (6.3%) (p = 0.002). Meta-analysis of the published results confirmed this observation with 45.7% low suppressors in T1D and 7.8% in controls (p = 0.00002). Interestingly, suppression assays using heterologous Tregs, effector T cells and APC suggest that the source of APC is correlated with the suppression activity. The frequencies of CD4+CD25+ and CD4+CD25hi T cells were found to increase with age in normal controls but not in T1D patients, resulting in significantly higher frequencies of CD4+CD25+ (p = 0.001) and CD4+CD25hi (p = 0.009) T cells in young T1D subjects than age-matched controls but slightly lower CD4+CD25+ (p = 0.003) and CD4+CD25hi (p = 0.08) T cells in old T1D subjects than age-matched controls.

Original languageEnglish (US)
Pages (from-to)272-279
Number of pages8
JournalClinical Immunology
Volume130
Issue number3
DOIs
StatePublished - Mar 1 2009

Fingerprint

Antigen-Presenting Cells
Type 1 Diabetes Mellitus
Cell Proliferation
T-Lymphocytes
Viral Tumor Antigens
Regulatory T-Lymphocytes
Autoimmune Diseases
Meta-Analysis
Tissue Donors
In Vitro Techniques

Keywords

  • Antigen presenting cells
  • Autoimmunity
  • Regulatory T cells
  • Suppression
  • Type 1 diabetes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes. / Jin, Yulan; Chen, Xueqin; Podolsky, Robert; Hopkins, Diane; Makala, Levi H; Muir, Andy; She, Jin-Xiong.

In: Clinical Immunology, Vol. 130, No. 3, 01.03.2009, p. 272-279.

Research output: Contribution to journalArticle

Jin, Yulan ; Chen, Xueqin ; Podolsky, Robert ; Hopkins, Diane ; Makala, Levi H ; Muir, Andy ; She, Jin-Xiong. / APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes. In: Clinical Immunology. 2009 ; Vol. 130, No. 3. pp. 272-279.
@article{2b22236c2748417d9889ff3f6f512c35,
title = "APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes",
abstract = "It is widely believed that CD4+CD25+ regulatory T cells (Treg) are defective in type 1 diabetes (T1D) and other autoimmune diseases. However, this conclusion is based on the suboptimal in vitro suppression results from very small numbers of subjects. Furthermore, the cells responsible for the suboptimal suppression have not been defined. Therefore, we carried out extensive in vitro suppression assays using both autologous and heterologous donors of Tregs, effector T cells and antigen-presenting cells (APC) from both T1D patients and normal controls. Our in vitro suppression data indicated that a significantly higher proportion (40.0{\%}) of T1D patients have {"}very low suppression{"} activity (defined as < 25{\%}) by autologous Treg compared to controls (6.3{\%}) (p = 0.002). Meta-analysis of the published results confirmed this observation with 45.7{\%} low suppressors in T1D and 7.8{\%} in controls (p = 0.00002). Interestingly, suppression assays using heterologous Tregs, effector T cells and APC suggest that the source of APC is correlated with the suppression activity. The frequencies of CD4+CD25+ and CD4+CD25hi T cells were found to increase with age in normal controls but not in T1D patients, resulting in significantly higher frequencies of CD4+CD25+ (p = 0.001) and CD4+CD25hi (p = 0.009) T cells in young T1D subjects than age-matched controls but slightly lower CD4+CD25+ (p = 0.003) and CD4+CD25hi (p = 0.08) T cells in old T1D subjects than age-matched controls.",
keywords = "Antigen presenting cells, Autoimmunity, Regulatory T cells, Suppression, Type 1 diabetes",
author = "Yulan Jin and Xueqin Chen and Robert Podolsky and Diane Hopkins and Makala, {Levi H} and Andy Muir and Jin-Xiong She",
year = "2009",
month = "3",
day = "1",
doi = "10.1016/j.clim.2008.10.005",
language = "English (US)",
volume = "130",
pages = "272--279",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes

AU - Jin, Yulan

AU - Chen, Xueqin

AU - Podolsky, Robert

AU - Hopkins, Diane

AU - Makala, Levi H

AU - Muir, Andy

AU - She, Jin-Xiong

PY - 2009/3/1

Y1 - 2009/3/1

N2 - It is widely believed that CD4+CD25+ regulatory T cells (Treg) are defective in type 1 diabetes (T1D) and other autoimmune diseases. However, this conclusion is based on the suboptimal in vitro suppression results from very small numbers of subjects. Furthermore, the cells responsible for the suboptimal suppression have not been defined. Therefore, we carried out extensive in vitro suppression assays using both autologous and heterologous donors of Tregs, effector T cells and antigen-presenting cells (APC) from both T1D patients and normal controls. Our in vitro suppression data indicated that a significantly higher proportion (40.0%) of T1D patients have "very low suppression" activity (defined as < 25%) by autologous Treg compared to controls (6.3%) (p = 0.002). Meta-analysis of the published results confirmed this observation with 45.7% low suppressors in T1D and 7.8% in controls (p = 0.00002). Interestingly, suppression assays using heterologous Tregs, effector T cells and APC suggest that the source of APC is correlated with the suppression activity. The frequencies of CD4+CD25+ and CD4+CD25hi T cells were found to increase with age in normal controls but not in T1D patients, resulting in significantly higher frequencies of CD4+CD25+ (p = 0.001) and CD4+CD25hi (p = 0.009) T cells in young T1D subjects than age-matched controls but slightly lower CD4+CD25+ (p = 0.003) and CD4+CD25hi (p = 0.08) T cells in old T1D subjects than age-matched controls.

AB - It is widely believed that CD4+CD25+ regulatory T cells (Treg) are defective in type 1 diabetes (T1D) and other autoimmune diseases. However, this conclusion is based on the suboptimal in vitro suppression results from very small numbers of subjects. Furthermore, the cells responsible for the suboptimal suppression have not been defined. Therefore, we carried out extensive in vitro suppression assays using both autologous and heterologous donors of Tregs, effector T cells and antigen-presenting cells (APC) from both T1D patients and normal controls. Our in vitro suppression data indicated that a significantly higher proportion (40.0%) of T1D patients have "very low suppression" activity (defined as < 25%) by autologous Treg compared to controls (6.3%) (p = 0.002). Meta-analysis of the published results confirmed this observation with 45.7% low suppressors in T1D and 7.8% in controls (p = 0.00002). Interestingly, suppression assays using heterologous Tregs, effector T cells and APC suggest that the source of APC is correlated with the suppression activity. The frequencies of CD4+CD25+ and CD4+CD25hi T cells were found to increase with age in normal controls but not in T1D patients, resulting in significantly higher frequencies of CD4+CD25+ (p = 0.001) and CD4+CD25hi (p = 0.009) T cells in young T1D subjects than age-matched controls but slightly lower CD4+CD25+ (p = 0.003) and CD4+CD25hi (p = 0.08) T cells in old T1D subjects than age-matched controls.

KW - Antigen presenting cells

KW - Autoimmunity

KW - Regulatory T cells

KW - Suppression

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=59249097729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59249097729&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2008.10.005

DO - 10.1016/j.clim.2008.10.005

M3 - Article

VL - 130

SP - 272

EP - 279

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -